|

Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial

RECRUITINGN/ASponsored by Peking University First Hospital
Actively Recruiting
PhaseN/A
SponsorPeking University First Hospital
Started2022-10-24
Est. completion2024-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06324825

Summary

Fuzheng Nizeng Formula (FZNZ) is derived from the classic formula Liujunzi Decoction. Former pilot study found that FZNZ promoted the recovery of gastric atrophy and relieve the relative symptoms. This study is to evaluate its efficacy for chronic atrophic gastritis with low-grade intraepithelial neoplasia, compared with positive control Molduodan granule.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia diagnosed by endoscopy and stomach biopsy.
* Helicobacter pylori negative.
* TCM syndrome is spleen-stomach deficiency with blood stasis and phelgm.

Exclusion Criteria:

* History of gastric surgery.
* Combined with malignant tumor.
* History of mental illness.
* Allergy to any components of the drug use in the study.
* Planning to pregnancy, or pregnant woman and lactating woman.

Conditions2

Atrophic Gastritis With Low-grade Intraepithelial NeoplasiaCancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.